June 1, 2026 · Arthritis & rheumatology (Hoboken, N.J.) · DOI: 10.1002/art.70236

Integrated Clinical and Proteomic Profiling of CD19 CAR-T Cell Therapy in Progressive Systemic Sclerosis

Listen to this summary

The authors aimed to characterize the clinical, immunologic, and proteomic changes associated with CD19 CAR-T cell therapy in patients with progressive systemic sclerosis. The study found that this therapy resulted in manageable safety profiles and significant clinical improvements, alongside notable changes in plasma proteins related to inflammation and fibrosis. These findings suggest that CAR-T therapy induces broad remodeling of disease-related pathways, warranting further investigation in larger cohorts.

Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play